• Comment: Where is the substantive description or discussion of Endpoints News (EN), in reliable sources independent of EN and of each other?
    I noticed Endpoints News' reporting has been referenced in Semafor, CNBC, The New York Times, Wall Street Journal, and NPR. I clicked on the reference for the first of these. (Tip, one has to be quick to search within the page for "Endpoints" -- before an obnoxious and irremovable pop-up takes over the screen.) No description or discussion of EN, thus no evidence for notability. If any of the other four says something worth summarizing, then summarize it; if it doesn't, then skip any mention of it. -- Hoary (talk) 02:08, 8 July 2025 (UTC)

Endpoints News is an American digital news publication focused on the biotechnology and pharmaceutical industries. Founded in 2016 by John Carroll and Arsalan Arif, it reports on drug development, regulatory affairs, and biotech investment. In 2023, the Financial Times acquired a controlling stake in the company to expand its coverage of the biopharmaceutical industry.[1][2].

Drew Armstrong was appointed executive editor in 2022 after serving as Bloomberg’s senior editor for health care[3].

Media Appearances

edit

In 2023, the Financial Times acquired a majority stake in Endpoints News. Reuters[1] reported that the acquisition reflected the FT’s strategy to expand into the U.S. and biopharma markets, while Axios[4] published an interview with FT executive Matt Fottrell on the motivations for the deal. The media industry outlet A Media Operator[5] analyzed the potential implications of the acquisition for Endpoints News’ subscription model.

Endpoints News reporting has been cited by mainstream and pharmaceutical news organizations. In 2025, the outlet first reported on FDA official Vinay Prasad’s departure[6] and subsequent return[7], coverage later referenced by Reuters[8], The Guardian[9][10], and Fierce Pharma[11].

Other examples of recognition include Semafor highlighting Endpoints reporting on the pharmaceutical industry’s leadership under a potential second Trump administration[12]; CNBC crediting Endpoints with breaking news of staff cuts at health company Noom[13]; The New York Times quoting founding editor John Carroll as an industry voice during the COVID-19 pandemic in an article about Biogen's super-spreader event[14]; and a Wall Street Journal op-ed on the Inflation Reduction Act citing Endpoints’ exclusive reporting on Eli Lilly’s cancellation of a cancer treatment[15][16].

Recognition

edit

Awards received:

  • SABEW Best in Business HealthTech newsletter[17]
  • 2025 Jesse H. Neal Awards for Best eNewsletter and Best Generative AI Content[18]

References

edit
  1. ^ a b "CORRECTED-Financial Times acquires majority stake in medical publication Endpoints News (April 3)". Reuters. 2023-04-05. Retrieved 2025-06-19.
  2. ^ Tobitt, Charlotte (2023-04-04). "FT takes majority stake in biopharma B2B site Endpoints News". Press Gazette. Retrieved 2025-07-07.
  3. ^ Roush, Chris (2022-11-01). "Endpoints hires Armstrong as executive editor". Talking Biz News. Retrieved 2025-07-07.
  4. ^ Flynn, Kerry (2023-05-01). "Financial Times' Matt Fottrell chats M&A strategy". Axios. Retrieved 2025-08-22.
  5. ^ Donnelly, Jacob Cohen (2023-04-04). "Multiple Deals Show Opportunity in Niche Media". A Media Operator. Retrieved 2025-08-22.
  6. ^ "Vinay Prasad is out at FDA, following Sarepta decision and vaccine controversies". Endpoints News. Retrieved 2025-08-22.
  7. ^ "Prasad returns to FDA, resuming head of CBER role". Endpoints News. Retrieved 2025-08-22.
  8. ^ "Vinay Prasad returns to role as top vaccine regulator at FDA days after leaving US agency". Reuters. 2025-08-11. Retrieved 2025-08-22.
  9. ^ "FDA's top vaccine official leaves post after less than four months". The Guardian. 2025-07-30. ISSN 0261-3077. Retrieved 2025-08-22.
  10. ^ "Vinay Prasad returns to FDA days after leaving under pressure from Laura Loomer". The Guardian. 2025-08-09. ISSN 0261-3077. Retrieved 2025-08-22.
  11. ^ Liu, Angus (2025-07-31). "Vinay Prasad exit signals more permissive FDA for cell and gene field". www.fiercepharma.com. Retrieved 2025-08-22.
  12. ^ "American business leaders are turning on Trump — fast". Archived from the original on 2025-07-28. Retrieved 2025-08-22.
  13. ^ Capoot, Annika Kim Constantino,Ashley (2025-02-04). "Healthy Returns: Why people quit weight loss and diabetes drugs within one year". CNBC. Retrieved 2025-08-22.{{cite web}}: CS1 maint: multiple names: authors list (link)
  14. ^ "How a Premier U.S. Drug Company Became a Virus 'Super Spreader' (Published 2020)". 2020-04-12. Retrieved 2025-08-22.
  15. ^ Grogan, Joe (2022-11-03). "Opinion | The Inflation Reduction Act Is Already Killing Potential Cures". Wall Street Journal. ISSN 0099-9660. Retrieved 2025-08-22.
  16. ^ cwadmin (2022-11-04). "The Inflation Reduction Act Is Already Killing Potential Cures - November 3, 2022". USC Schaeffer. Retrieved 2025-08-22.
  17. ^ "2024 Best in Business Awards". SABEW. Retrieved 2025-06-19.
  18. ^ "2025 Neal Awards Winners". Neals. Retrieved 2025-06-19.